Dr. Leslie Chu is the Founder of Artem Nova LLC, with over 20 years’ experience in regulatory writing and scientific communications. She holds a PhD in Biomedical Sciences and is RAC certified.

Dr. Chu has consulted for over 65 pharmaceutical and biotechnology companies. She has extensive experience in small molecule, biologic, and device development. Dr. Chu brings her broad medical writing expertise and strong understanding of regulations to craft and hone preclinical, clinical, regulatory, and scientific documents and communications. She is a creative and adaptable project manager, with a steadfast commitment to excellence.